Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2011, Article ID 401258, 8 pages
http://dx.doi.org/10.1155/2011/401258
Research Article

β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia

1Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, Denmark
2Section for Metabolic Receptology and Enteroendocrinology, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Blegdamsvej 3, 2200 Copenhagen, Denmark
3Division of Diabetes, Metabolism, and Endocrinology, Department of Experimental Medical Science, Lund University, Lund, Sweden

Received 24 June 2011; Accepted 7 September 2011

Academic Editor: Maria L. Dufau

Copyright © 2011 Kristoffer L. Egerod et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Feighner, C. P. Tan, K. K. McKee et al., “Receptor for motilin identified in the human gastrointestinal system,” Science, vol. 284, no. 5423, pp. 2184–2188, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Holst, N. D. Holliday, A. Bach, C. E. Elling, H. M. Cox, and T. W. Schwartz, “Common structural basis for constitutive activity of the ghrelin receptor family,” Journal of Biological Chemistry, vol. 279, no. 51, pp. 53806–53817, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Holst and T. W. Schwartz, “Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation,” Trends in Pharmacological Sciences, vol. 25, no. 3, pp. 113–117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. D. Howard, R. Wang, S. S. Pong et al., “Identification of receptors for neuromedin U and its role in feeding,” Nature, vol. 406, no. 6791, pp. 70–74, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Zhao and C. Pothoulakis, “Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation,” Peptides, vol. 27, no. 10, pp. 2434–2444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. K. L. Egerod, B. Holst, P. S. Petersen et al., “GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue,” Molecular Endocrinology, vol. 21, no. 7, pp. 1685–1698, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Moechars, I. Depoortere, B. Moreaux et al., “Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse,” Gastroenterology, vol. 131, no. 4, pp. 1131–1141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. P. P. G. Gerber, E. R. Trimble, and C. B. Wollheim, “Glucose and cyclic AMP as stimulators of somatostatin and insulin secretion from the isolated, perfused rat pancreas. A quantitative study,” Diabetes, vol. 30, no. 1, pp. 40–44, 1981. View at Google Scholar · View at Scopus
  9. H. Ishihara, P. Maechler, A. Gjinovci, P.-L. Herrera, and C. B. Wollheim, “Islet β-cell secretion determines glucagon release from neigbouring α-cells,” Nature Cell Biology, vol. 5, no. 4, pp. 330–335, 2003. View at Publisher · View at Google Scholar
  10. J. V. Zhang, P. G. Ren, O. Avsian-Kretchmer et al., “Medicine: obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake,” Science, vol. 310, no. 5750, pp. 996–999, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Chartrel, R. Alvear-Perez, J. Leprince et al., “Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake",” Science, vol. 315, no. 5813, p. 766, 2007. View at Google Scholar · View at Scopus
  12. B. Holst, K. L. Egerod, E. Schild et al., “GPR39 signaling is stimulated by zinc ions but not by obestatin,” Endocrinology, vol. 148, no. 1, pp. 13–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Lauwers, B. Landuyt, L. Arckens, L. Schoofs, and W. Luyten, “Obestatin does not activate orphan G protein-coupled receptor GPR39,” Biochemical and Biophysical Research Communications, vol. 351, no. 1, pp. 21–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Tremblay, M. Perreault, L. D. Klaman, J. F. Tobin, E. Smith, and R. E. Gimeno, “Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39,” Endocrinology, vol. 148, no. 2, pp. 501–506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. V. Zhang, C. Klein, P. G. Ren et al., “Response to comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake",” Science, vol. 315, no. 5813, p. 766, 2007. View at Google Scholar · View at Scopus
  16. B. Holst, K. L. Egerod, C. Jin et al., “G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction,” Endocrinology, vol. 150, no. 6, pp. 2577–2585, 2009. View at Publisher · View at Google Scholar
  17. F. Tremblay, A. M. T. Richard, S. Will et al., “Disruption of G protein-coupled receptor 39 impairs insulin secretion in vivo,” Endocrinology, vol. 150, no. 6, pp. 2586–2595, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Dittmer, M. Sahin, A. Pantlen et al., “The constitutively active orphan G-protein-coupled receptor GPR39 protects from cell death by increasing secretion of pigment epithelium-derived growth factor,” Journal of Biological Chemistry, vol. 283, no. 11, pp. 7074–7081, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Kistner, M. Gossen, F. Zimmermann et al., “Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 20, pp. 10933–10938, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Zhu, T. Zheng, C. G. Lee, R. J. Homer, and J. A. Elias, “Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling,” Seminars in Cell and Developmental Biology, vol. 13, no. 2, pp. 121–128, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. A. A. Like and A. A. Rossini, “Streptozotocin induced pancreatic insulitis: new model of diabetes mellitus,” Science, vol. 193, no. 4251, pp. 415–417, 1976. View at Google Scholar · View at Scopus
  22. N. Wierup, M. Kuhar, B. O. Nilsson, H. Mulder, E. Ekblad, and F. Sundler, “Cocaine- and amphetamine-regulated transcript (CART) is expressed in several islet cell types during rat development,” Journal of Histochemistry and Cytochemistry, vol. 52, no. 2, pp. 169–177, 2004. View at Google Scholar · View at Scopus
  23. L. Härndahl, N. Wierup, S. Enerbäck et al., “β-cell-targeted overexpression of phosphodiesterase 3B in mice causes impaired insulin secretion, glucose intolerance, and deranged islet morphology,” Journal of Biological Chemistry, vol. 279, no. 15, pp. 15214–15222, 2004. View at Publisher · View at Google Scholar
  24. M. K. Thomas, O. N. Devon, J. H. Lee et al., “Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1,” Journal of Clinical Investigation, vol. 108, no. 2, pp. 319–329, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Johansen, C. Rosenblad, K. Andsberg et al., “Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS,” Gene Therapy, vol. 9, no. 19, pp. 1291–1301, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Mulder, B. Ahrén, and F. Sundler, “Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents,” Molecular and Cellular Endocrinology, vol. 114, no. 1-2, pp. 101–109, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. E. H. Leiter, “Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 79, no. 2, pp. 630–634, 1982. View at Google Scholar · View at Scopus
  28. J. M. Guettier, D. Gautam, M. Scarselli et al., “A chemical-genetic approach to study G protein regulation of β cell function in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 45, pp. 19197–19202, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. K. K. McKee, C. P. Tan, O. C. Palyha et al., “Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors,” Genomics, vol. 46, no. 3, pp. 426–434, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. B. A. Jones and G. J. Gores, “Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine,” American Journal of Physiology, vol. 273, no. 6, pp. G1174–G1188, 1997. View at Google Scholar · View at Scopus
  31. P. Schott-Ohly, A. Lgssiar, H. J. Partke, M. Hassan, N. Friesen, and H. Gleichmann, “Prevention of spontaneous and experimentally induced diabetes in mice with zinc sulfate-enriched drinking water is associated with activation and reduction of NF-κB and AP-1 in islets, respectively,” Experimental Biology and Medicine, vol. 229, no. 11, pp. 1177–1185, 2004. View at Google Scholar · View at Scopus
  32. P. Ohly, C. Dohle, J. Abel, J. Seissler, and H. Gleichmann, “Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin,” Diabetologia, vol. 43, no. 8, pp. 1020–1030, 2000. View at Google Scholar · View at Scopus
  33. M. H. Tobia, M. M. Zdanowicz, M. A. Wingertzahn, B. McHeffey-Atkinson, A. E. Slonim, and R. A. Wapnir, “The role of dietary zinc in modifying the onset and severity of spontaneous diabetes in the BB Wistar rat,” Molecular Genetics and Metabolism, vol. 63, no. 3, pp. 205–213, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Kaneto, T. A. Matsuoka, N. Katakami et al., “Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes,” Current Molecular Medicine, vol. 7, no. 7, pp. 674–686, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Are oxidative stress—activated signaling pathways mediators of insulin resistance and β-cell dysfunction?” Diabetes, vol. 52, no. 1, pp. 1–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. J. W. Adams and J. H. Brown, “G-proteins in growth and apoptosis: lessons from the heart,” Oncogene, vol. 20, no. 13, pp. 1626–1634, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. K. B. Hubbard and J. R. Hepler, “Cell signalling diversity of the Gqα family of heterotrimeric G proteins,” Cellular Signalling, vol. 18, no. 2, pp. 135–150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Mata, S. Marguerat, and J. Bähler, “Post-transcriptional control of gene expression: a genome-wide perspective,” Trends in Biochemical Sciences, vol. 30, no. 9, pp. 506–514, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Gry, R. Rimini, S. Strömberg et al., “Correlations between RNA and protein expression profiles in 23 human cell lines,” BMC Genomics, vol. 10, article 365, 2009. View at Publisher · View at Google Scholar